Blood cell clues could predict transplant danger
NCT ID NCT02194868
First seen Nov 20, 2025 · Last updated Apr 28, 2026 · Updated 30 times
Summary
This study examined blood samples from 57 people who received stem cell transplants for blood cancers. Researchers looked at specific immune cells to see if they could predict a serious complication called graft-versus-host disease, where donor cells attack the patient's body. The goal was to find patterns that could help doctors personalize care and reduce risks after transplant.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR HEMATOLOGICAL MALIGNANCIES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hopital Necker
Paris, 75015, France
Conditions
Explore the condition pages connected to this study.